Clinical trial
A Randomized Controlled Study to Explore the Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
NCT06319534 is registered in ClinicalTrials.gov with Zeng Xi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study to Explore the Effect of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke
- Lead sponsor
- Zeng Xi
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 23, 2024
- Completion date
- July 5, 2025
- Enrollment
- 124 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
bulbar palsy